Biprogy (8056.T): Q1 results - Negative, revenue recognition delays due to system integration issues

Research evidence excerpt

Flash |

05 Aug 2026 06:54:25 ET │ 10 pages

Biprogy (8056.T)

Q1 results - Negative, revenue recognition delays due to system

integration issues

CITI'S TAKE

Buy

Price (05 Aug 26 15:30)

¥4,736.0

Target price

¥5,300.0

Expected share price return

11.9%

Expected dividend yield

3.0%

Expected total return

14.9%

Market Cap

¥457,573M

US$2,901M

Q1 results leave a negative impression, as earnings significantly missed

consensus due to revenue recognition delays from system integration

issues, primarily in software and hardware. Q1 OP fell 20% YoY to ¥6.8bn,

significantly below the ¥9.1bn consensus. The shortfall was partly the

result of delays in procurement operations caused by data inconsistencies

during core system integration with subsidiary Uniadex, resulting in

revenue and gross profit delays of c¥6bn and ¥1bn, respectively. Even

excluding this impact, OP missed consensus due to delayed orders for

small and medium-sized projects as the firm focused on securing largescale projects. Meanwhile, the order backlog grew 26% YoY to ¥119.9bn,

performing strongly driven by hardware (+93% YoY) including GPU cluster

construction projects fueled by AI-related demand.

Moriya KoketsuAC

Implications — The system renewal delays were unexpected, and the OP shortfall

creates a negative impression. While orders remain strong and we expect revenue

recognition from the aforementioned GPU cluster construction project (¥20bn in

revenue) in H2, concerns about further revenue recognition delays due to system

issues may persist, and we believe the shares will likely remain weak.

Consol.

3/25A

Sales

OP

RP

NP

EPS

PE

¥M

YOY (%)

¥M

YOY (%)

OPM(%)

¥M

YOY (%)

¥M

YOY (%)

X

404,010

9.2

39,067

17.4

9.7

38,790

13.5

26,967

6.8

273

17.4

3/26A

433,686

7.3

42,604

9.1

9.8

43,846

13.0

31,211

15.7

321

14.8

3/27CE

470,000

8.4

48,400

13.6

10.3

na

32,200

3.2

333

14.2

3/27E

476,130

9.8

48,050

12.8

10.1

48,050

9.6

32,130

2.9

334

14.2

3/28E

504,500

6.0

53,050

10.4

10.5

53,050

10.4

35,510

10.5

373

12.7

3/29E

526,480

4.4

56,880

7.2

10.8

56,880

7.2

38,110

7.3

405

11.7

A: Actuals, E: Citi Research Ests, CE: Co. Ests, RE: Citi Research Revised Ests, CRE: Co. Revised Ests, NA: Not Available, NM: Not Meaningful